Jyong Biotech: Navigating Market Swings and Future Plans

Taiwan-Based Biotech Company Observes Unusual Stock Activity

Jyong Biotech, a biotech company based in Taiwan, has noticed some unusual activity in its stock price and trading volume. This comes just after a lock-up period ended this month. The company is in talks with some investment funds about buying shares, but they say they're not hiding any big news that could explain the market moves.

Company's Current Status

They're doing okay. Their research, operations, and finances are all in line with what they've told investors before. However, they remind everyone that stock prices can be shaky for lots of reasons, like market trends or industry news, and those aren't always in their control.

Future Developments and Goals

Jyong Biotech is working on some big things. They've finished several clinical trials and have plans to keep developing new plant-based medicines. They've even got patents in different countries and are teaming up with other pharma companies to grow globally. Their goal? To make better medicines for people who need them.

Company Background

The company started back in 2002 and has been working on drugs for urinary system diseases. They've got a few drugs in the works, like BOTRESO®, and they're aiming to be a top player in the biotech world.

Forward-Looking Statements

Now, they had to say something about the future. They made some predictions, but those come with risks. Market conditions can change, and things might not go as planned. So, they're not making any promises, and they're telling investors not to rely too much on their forward-looking statements.